Events Partner Content STING & TLR Targeting Therapies Summit Investigating the cGAS-STING and TLR pathways
Events Partner Content TIGIT Therapies Digital Summit Harnessing TIGIT Checkpoint Inhibitor Therapies
Partner Content Partner Content Updates on Keytruda and future potential therapies advanceme... SMi Group reports on preparations for SMi's inaugural Immuno-Oncology Conference, which is scheduled to take place 26 - 27 September in London.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
